Making sense of the market reaction to vaccine developments

We think that the relatively muted gains in most equity markets in recent weeks reflects how positive news about potential COVID-19 vaccines has been partly offset by the renewed surge of infections in many advanced economies. If this resurgence peters out and there is more good news about vaccines, we think stock markets could make further headway.

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.


Free. 10 articles. No card required.
By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.

Already a client or trialist? Log in to read this.